Tivicay
Product Images NDC 67296-1818

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tivicay (NDC 67296-1818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 Count (67296 1818 3)

NDC 67296-1818-3 is the identifier for TIVICAY, a prescription medicine in the form of 50mg tablets. Each package contains three tablets, with Lot TS4PX1 and an expiration date of 03/25. Adult dosages are indicated in the package insert. The medicine should be stored at a controlled room temperature of 20-25°C (68-77°F). The manufacturer is GlaxoSmithKline, with an address of 25 Research Triangle Park, NC 27709. The distributor is Redpharm Drug, and the product ID is SIN136754. No additional information is available.*

FDA Label Image

Dolutegravir Chemical Structure (Tivicay Spl Graphic 01)

FDA Label Image

Tivicay Pack (Tivicay Spl Graphic 02)

FDA Label Image

Figure A (Tivicay Spl Graphic 03)

FDA Label Image

Figure B And Figure C (Tivicay Spl Graphic 04)

FDA Label Image

Figure D (Tivicay Spl Graphic 05)

The text provides a simple instruction to give medicine to a child.*

FDA Label Image

Figure E And Figure F (Tivicay Spl Graphic 06)

Simple instruction to administer medicine to an infant.*

FDA Label Image

Figure G And Figure H (Tivicay Spl Graphic 07)

FDA Label Image

Tivicay Pd 5 mg 60 Count Carton (Tivicay Spl Graphic 08)

Tivicay PD is a prescription drug that comes in a bottle of 60 tablets and a dosing syringe. Each tablet contains 5mg of dolutegravir. It is important not to chew, cut, or crush this tablet for oral suspension. Tivicay and Tivicay PD are not interchangeable. Prescription information should be followed closely.*

FDA Label Image

Tivicay 10 mg 30 Count Label (Tivicay Spl Graphic 09)

Tivicay (dolutegravir) Tablets are available in a pack of 30 and each film-coated tablet contains dolutegravir sodium equivalent to 10 mg of dolutegravir. It is preferably stored in its original package at a controlled room temperature of 25°C (77°F) excursions permitted to 1510 30°C (59'086'F) (as per the USP). The bottle should be kept tightly closed and protected from moisture. The prescribing information should be referred to for dosage information. This medication is only available on prescription.*

FDA Label Image

Tivicay 25 mg Count Label (Tivicay Spl Graphic 10)

This is a prescription drug labeled as "Ivicay" with the generic name "dolutegravir". It comes in the form of film-coated tablets containing 25 mg of dolutegravir sodium per tablet. The medication should be stored at a controlled room temperature between 25°C (77°F) and excursions allowed between 10-30°C (59° to 86°F). The prescribing information should be consulted for dosage instructions. The drug is manufactured in Japan by Viv ExE and the contact information is mentioned for Research Triangle Park, NC 27709.*

FDA Label Image

Tivicay 50 mg 30 Count Label (Tivicay Spl Graphic 11)

This is a prescription medicine called Tivicay with the generic name dolutegravir which comes in tablets of 50 mg. The bottle contains 30 tablets and suggests storing at controlled room temperature between 15 to 30°C (59° to 86°F). The manufacturer is ViiV Healthcare located in RTP, NC. This medicine is specifically used for treating HIV infection. Please check the prescribing information for the dosage. Some contact information is also included on the label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.